<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="132939">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02073578</url>
  </required_header>
  <id_info>
    <org_study_id>2011H0240</org_study_id>
    <nct_id>NCT02073578</nct_id>
  </id_info>
  <brief_title>Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia</brief_title>
  <acronym>POEM</acronym>
  <official_title>Peroral Endoscopic Myotomy (POEM) for the Treatment of Achalasia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ohio State University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ohio State University</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study for a new endoscopic treatment of achalasia. Up to 25 patients will be
      recruited for this trial, with the intent to treat 20 patients.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>August 2012</start_date>
  <completion_date type="Anticipated">July 2015</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Adverse Events related to POEM</measure>
    <time_frame>Intraoperative to one year follow-up</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>To assess adverse events related to POEM</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Quality of life</measure>
    <time_frame>Baseline to one year follow-up</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess change in quality of life from baseline, based on validated quality of life measures, at baseline through 1 year follow-up. It is expected that quality of life measures will improve post-POEM.</description>
  </primary_outcome>
  <enrollment type="Actual">20</enrollment>
  <condition>Achalasia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Peroral Endoscopic Myotomy (POEM)</intervention_name>
    <description>Endoscopy myotomy for treatment of achalasia</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of Achalasia

          -  Age 16-80

          -  ASA Class 1-3

        Exclusion Criteria:

          -  Pregnancy

          -  Any prior surgical or endoscopic treatment for achalasia -- first eight subjects.

        After eight subjects have been treated as part of this study, this exclusion criteria no
        longer applies

          -  Patients who are taking immunosuppressive medications or are immunocompromised

          -  Patients on anticoagulant medications or abnormal coagulation tests

          -  Patients with severe medical comorbidities, in the judgment of the treating surgeon
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Vimal K Narula, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ohio State University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Ohio State University Wexner Medical Center</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 25, 2014</lastchanged_date>
  <firstreceived_date>February 24, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ohio State University</investigator_affiliation>
    <investigator_full_name>Kyle A Perry</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>achalasia</keyword>
  <keyword>POEM</keyword>
  <keyword>peroral endoscopic myotomy</keyword>
  <keyword>myotomy</keyword>
  <keyword>Heller myotomy</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Esophageal Achalasia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
